Applied Genetic Technologies Corp (AGTC)

Add to Watchlists
Create an Alert
3.02 +0.02  +0.67% NASDAQ Aug 22, 11:49 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
09/10/2019 08:00 EDT Misc Applied Genetic Technologies Corp Fourth Quarter Earnings Conference Call in 2019
09/10/2019 Earnings Applied Genetic Technologies Corp Fourth Quarter Earnings in 2019 Release
05/07/2019 16:30 EDT Misc Applied Genetic Technologies Corp Third Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Applied Genetic Technologies Corp Third Quarter Earnings in 2019 Release
02/07/2019 08:00 EST Misc Applied Genetic Technologies Corp Second Quarter Earnings Conference Call in 2019
02/07/2019 Earnings Applied Genetic Technologies Corp Second Quarter Earnings in 2019 Release
11/08/2018 08:00 EST Misc Applied Genetic Technologies Corp First Quarter Earnings Conference Call in 2019
11/08/2018 Earnings Applied Genetic Technologies Corp First Quarter Earnings in 2019 Release
09/10/2018 16:30 EDT Misc Applied Genetic Technologies Corp Fourth Quarter Earnings Conference Call in 2018
09/10/2018 Earnings Applied Genetic Technologies Corp Fourth Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.agtc.com
  • Investor Relations URL: http://ir.agtc.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Sep. 10, 2019
  • Last Earnings Release: May. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 & ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("AGTC","name")
  • Description: =YCI("AGTC","description")
  • Sector: =YCI("AGTC","sector")
  • Industry: =YCI("AGTC","industry")
  • Est. Current Fiscal Year End: =YCI("AGTC","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.